All News

How risky are family gatherings, birthday parties and informal social gatherings? Read more… https://t.co/jyGHakndUt https://t.co/7eps0EFVWy

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast square

RheumNow Podcast – As Good As I Ever Was (7.2.2021)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.

Read Article
CDC: as of 5/15/2021; the rates of flu test positivity was 0.051-0.18% for the 2020-21 flu season - compared to usual rate of 10%-19% before COVID. Actual influenza hospitalizations dropped from 44.2 to 0.8/100 000 population https://t.co/N8b1sQWWIh

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast square

RheumNow Podcast – Modern Treatment of RA Pregnancy (6.25.2021)

d Jack Cush, MD

Dr. Jack Cush reviews this week’s news and journal reports featured on RheumNow.com.

Read Article
FDA has granted emergency use authorization (EUA) for Actemra (tocilizumab) us in treating hospitalized COVID-19 (adults and kids) patients on steroids and who require, supplemental oxygen, mechanical ventilation, or ECMO https://t.co/YAVfbykcti https://t.co/d7pS1lUXpa

Links:

Dr. John Cush RheumNow ( View Tweet)
party, adult, birthday, mardi

Birthday Gatherings Increase COVID-19 Risk

d Jack Cush, MD

How risky are family gatherings, birthday parties and informal social gatherings? A cross-sectional analysis suggests that birthdays may be associated with increased rates of COVID-19 infection within households where there is a high COVID-19 prevalence in the population. 

Read Article
Italian survey foud 82% of MSK healthcare workers willing to receive COVID-19 vaccine, but only 55% of their rheumatic Dz patients were as willing, even if they perceived they were at risk. Not out of fear or distrust. more education needed https://t.co/nPhhME2dnC

Links:

Dr. John Cush RheumNow ( View Tweet)

sick kid child temperature fever

Treatment of MIS-C COVID in Kids

d Jack Cush, MD

The NEJM has published results of a real-world efficacty trial showing that COVID infected children with the multisystem inflammatory syndrome in children (MIS-C) respond better to initial IVIG plus glucocorticoids (than IVIG alone) which was associated with less subsequent cardiovascular co

Read Article
Covid lung pneumonia corona (keep)

Tofacitinib Efficacy in COVID-19 Pneumonia

d Jack Cush, MD

NEJM has published the results of an observational trial wherein tofacitinib given to patients hospitalized with Covid-19 pneumonia, was shown to significantly lower risk of death or respiratory failure.

Read Article
meeting.audience.3.jpg

EULAR 2021 – Day 4 Report

d Jack Cush, MD

It's been nearly two weeks since EULAR 21 ended. There were several presentations on the last day; notably, the late breaking abstracts and others. Here are a few of my favorites from Day 4, the final day of the meeting.

Read Article
The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheums’ offices everywhere this year, and at #EULAR2021, data presented from Israel, has provided much-needed answers. https://t.co/PUa6deflTy https://t.co/cs4MwnIcdR

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast square

RheumNow Podcast - Best of EULAR 2021

d Jack Cush, MD

Dr. Jack Cush reviews and highlights his favorite abstracts and presentations from last week's virtual EULAR 2021 meeting.

Read Article
COVID vaccine vials

Israel provides COVID vaccine answers for rheumatic disease patients

d David Liew, FRACP

The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheumatologists’ offices everywhere this year, and at the EULAR 2021 Virtual Congress, data presented from Israel, one of the first countries to vaccinate on a br

Read Article
Mavrilimumab (GM-CSFi) phase II trial of COVID-19 PNA and systemic hyperinflammation ⭐️65% risk reduction in ventilation/death ⭐️no sig difference in ventilation requirement ⭐️no serious AE Abs#LB0001 #EULAR2021 @RheumNow

Robert B Chao, MD doctorRBC ( View Tweet)

This is by far the biggest rheum dx COVID vaccinated cohort described I'm aware of 👏 Looking forward to full paper, & we will need data with more pts, more details, cellular response etc. Nevertheless, invaluable & reassuring. So glad to see it at #EULAR2021 LB0003 @RheumNow https://t.co/jsHZjLdCTT
David Liew drdavidliew ( View Tweet)
6. Rheum disease activity was stable with COVID vaccination. (RA, PsA, axSpA, SLE - total n = 597) 7/ LB0003 #EULAR2021 @RheumNow https://t.co/xxkrunjPa0
David Liew drdavidliew ( View Tweet)
Israel was early to COVID vaccinate on mass scale. How well did the vaccine work in their rheum dx pts? rheum pts n=686 (vs controls n = 121) - fewer w immunogencity, but not bad (86% vs 100%) - safety good - dx activity stable more details below ⬇️ LB0003 #EULAR2021 @RheumNow https://t.co/h2WT404mkF
David Liew drdavidliew ( View Tweet)
Reassuring safety data from @rheum_covid COVAX registry on #COVID #vaccination in patients with #RMDs 👉🏼Vaccine welltolerated by most patients 👉🏼Most adverse events similar to gen population 👉🏼RMD flares were rare after vaccine 👉🏼#GetVaccinated! LB0002 @pedrommcmachado #EULAR2021 https://t.co/bheIcVZ9xa
Mrinalini Dey DrMiniDey ( View Tweet)
Would you use #Telemedicine (TM) to follow-up #SLE patients post #COVID? Dr So showed in an RCT (N=122),patient satisfaction and time-to-review were better in TM vs Face-to-Face. Although none had COVID, >pts in TM were hospitalised and trend to⬆️FU #EULAR2021 #POS1164 @RheumNow https://t.co/p7aWv4AVm7
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
#EULAR2021 OP0291 proposes focus score of 4+ as prognostic factor for lymphoma risk in Sjogrens Focus score 4+: ⬆️lymphoma risk ⬆️salivary gland swelling ⬆️autoantibodies ⬇️thyroiditis Authors propose 4yr follow-up biopsy in all pts Focus score 4+. @RheumNow

Eric Dein ejdein1 ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×